Nasal delivery process can be feasible for select large molecules like GLP-1, but success is highly molecule and formulation dependent, not a universal solution though
The FDA added increased risks for severe pancreatitis and acute kidney injury
Our volumizing complex comprised of next generation hyaluronic acid, biomimetic collagen fragments, bakuchiol plus amino acids works synergistically to improve skin impacted by GLP-1 induced facial volume loss and skin texture decline by addressing the appearance of deflation, loose, sagging, crepey skin texture, dehydration, and wrinkles
You will leave with the system and operational plans necessary for your clinic to grow and scale
Diabetes subgroup analysis actually shows slightly lower weight loss in diabetic patients (19.7% at 8mg dose) compared to non-diabetic patients (24.2% at 12mg dose)